Physiological differences between men and women may contribute to differential tumor development and progression in colon cancer patients, suggests a study led by USC researchers. “Taking gender into account when examining the genetic profile of patients may help those who will benefit from specific chemotherapy treatments,” said principal investigator Heinz-Josef Lenz, professor of medicine at the Keck School of Medicine of USC.
